| European Case Law Identifier: | ECLI:EP:BA:1992:T038388.19921201 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 01 December 1992 | ||||||||
| Case number: | T 0383/88 | ||||||||
| Application number: | 83307993.2 | ||||||||
| IPC class: | C07D 239/70 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | |||||||||
| Download and more information: |
|
||||||||
| Title of application: | Condensed amino pyrimidinones and their use in the treatment and prophylaxis of viral infections | ||||||||
| Applicant name: | Biomeasure Inc. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Novelty - overlapping group of compounds Extension beyond the content of the application as filed read in the light of common general knowledge - balance of probability is the wrong standard for deciding the allowability of amendments under Article 123(2) EPC - the slightest doubt as to the derivability of the amendment from the unamended document rules out the amendment - affidavit evidence Remittal to the Examining Division Novelty Amentments - added subject matter (yes) Catchword |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: | |||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t880383eu1.html
Date retrieved: 17 May 2021